Novavax, Inc. announced a private placement to issue 6,500,000 common shares at an issue price of $13 per share for the gross proceeds of $84,500,000 on August 8, 2023. The transaction will include participation from new investor SK bioscience Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56,600 KRW | -1.91% | -4.87% | -21.39% |
May. 03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
56,600 KRW | -1.91% | -4.87% | 3.19B | ||
15.5 USD | +2.31% | +19.14% | 2.18B | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.39% | 3.19B | |
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |
- Stock Market
- Equities
- A302440 Stock
- News SK bioscience Co.,Ltd.
- Novavax, Inc. announced that it expects to receive $84.5 million in funding from SK bioscience Co.,Ltd.